{"id":"W2005900338","doi":"10.1182/blood-2011-08-371989","title":"Fludarabine and rituximab for relapsed or refractory hairy cell leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Cladribine; Pentostatin; Fludarabine; Rituximab; Medicine; Purine analogue; Refractory (planetary science); Internal medicine; Hairy cell leukemia; Oncology; Leukemia; Gastroenterology; Chemotherapy; Lymphoma; Purine; Cyclophosphamide; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000258321,0.0002094876,0.0003775668,0.0004250132,0.0003330882,0.0002522281,0.0003010279,0.0003417054,0.001823351],"category_scores_gemma":[0.0004221956,0.00008159679,0.0002671085,0.0004470701,0.0002242021,0.0001413293,0.0001947437,0.0003044173,0.0004296266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001022916,"about_ca_system_score_gemma":0.001295357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008387578,"about_ca_topic_score_gemma":0.02829535,"domain_scores_codex":[0.9998343,0.00003526524,0.00001678288,0.00002108158,0.00004409638,0.00004840806],"domain_scores_gemma":[0.9998575,0.00002799524,0.00003342976,0.00001050062,0.000009623308,0.00006094898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.00410235,0.0007496875,0.4086725,0.0006799649,0.0001878717,0.05947488,0.0006851786,0.0007580093,0.02203258,0.0005671789,0.008782004,0.4933078],"study_design_scores_gemma":[0.001495223,0.004049769,0.7774496,0.0002758591,0.0002668811,0.1584496,0.000502085,0.000950047,0.005448293,0.0004845602,0.05059631,0.00003176934],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734023,0.01869253,0.0002829296,0.0006038884,0.00003587858,0.0001469866,0.0002097434,0.00004066987,0.006585056],"genre_scores_gemma":[0.9901052,0.005531819,0.0005518617,0.0006603108,0.00007918136,0.00005066616,0.0005496916,0.000007420831,0.002463698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008387578,"threshold_uncertainty_score":0.0166775,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02851578518528316,"score_gpt":0.3005836549119431,"score_spread":0.27206786972666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}